trending Market Intelligence /marketintelligence/en/news-insights/trending/hHHevAagqkmru1FkQR--RQ2 content esgSubNav
In This List

GT Biopharma's CFO resigns

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


GT Biopharma's CFO resigns

GT Biopharma Inc. said Steven Weldon resigned as CFO and director of the company, effective Oct. 11.

The Westlake Village, Calif.-based developer of cancer therapies said that Weldon's resignation did not result from any disagreement with the company.